Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | KDM6B | O15054 | 1/20 | 0.42 |
| ▸ | KDM5C | P41229 | 1/20 | 0.42 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.42 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.42 |
| ▸ | MGAM | O43451 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | SI | P14410 | 1/20 | 0.41 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.41 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.40 |
| ▸ | HAO1 | Q9UJM8 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | FEN1 | P39748 | 4/20 | 0.37 |
| ▸ | ERCC5 | P28715 | 3/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19423 | 0.97 | — | — | |
| SCHEMBL999954 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| SCHEMBL487638 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| SCHEMBL1966887 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| SCHEMBL2927603 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| SCHEMBL5420640 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| Water SCHEMBL7871948 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| SCHEMBL1245971 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| SCHEMBL8101936 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 | |
| SCHEMBL597935 | 0.94 | EGLN1 (0.42) | EGLN1KDM4EKDM6BKDM5CPHF8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 71 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030143252-A1 | Inorganic/organic complexes for reducing skin irritation | PHILIPPE MICHEL (FR) | 2003-07-31 | — | — | US | claimed |
| US-6521222-B1 | Topical cosmetics such as strontium 2,4-pentanedionate applied to keratin fibers, nails and/or mucous membranes for injuries, eczema, ulcers, fibrosis, psoriasis, pruritus, dermatitis, warts and for aging or wrinkle resistance | SOCIETE L'OREAL S.A. (FR) | 2003-02-18 | — | — | US | claimed |
| EP-1092426-A1 | Use of inorganic-organic complexes whitin a composition | L'OREAL (FR) | 2001-04-18 | — | — | EP | claimed |
| EP-2319817-B1 | Solvent Based Slurry Compositions for Making Environmental Barrier Coatings | GEN ELECTRIC (US) | 2025-07-09 | — | — | EP | disclosed |
| EP-2284138-B1 | Water based slurry compositions for making environmental barrier coatings | GEN ELECTRIC (US) | 2025-07-02 | — | — | EP | disclosed |
| EP-2287133-B1 | Methods for making water based environmental barrier coatings using sintering aids | GEN ELECTRIC (US) | 2023-01-11 | — | — | EP | disclosed |
| EP-2287135-B1 | Solvent based environmental barrier coatings for high temperature ceramic components | GEN ELECTRIC (US) | 2022-04-20 | — | — | EP | disclosed |
| EP-2284139-B1 | Environmental barrier coatings for high temperature ceramic components | GEN ELECTRIC (US) | 2021-03-03 | — | — | EP | disclosed |
| EP-2287137-B1 | Methods for making environmental barrier coatings using sintering aids | GEN ELECTRIC (US) | 2021-02-24 | — | — | EP | disclosed |
| EP-2379773-B1 | CMAS MITIGATION COMPOSITIONS, ENVIRONMENTAL BARRIER COATINGS COMPRISING THE SAME, AND CERAMIC COMPONENTS COMPRISING THE SAME | GEN ELECTRIC (US) | 2020-10-28 | — | — | EP | disclosed |
| EP-2287136-B1 | Methods of Improving Surface Roughness of an Environmental Barrier Coating and Components Comprising Environmental Barrier Coatings Having Improved Surface Roughness | GEN ELECTRIC (US) | 2020-04-08 | — | — | EP | disclosed |
| WO-2010080241-A1 | METHODS FOR MAKING ENVIRONMENTAL BARRIER COATINGS AND CERAMIC COMPONENTS HAVING CMAS MITIGATION CAPABILITY | GENERAL ELECTRIC COMPANY (US) | 2010-07-15 | — | — | WO | disclosed |
| US-20100154422-A1 | CMAS MITIGATION COMPOSITIONS, ENVIRONMENTAL BARRIER COATINGS COMPRISING THE SAME, AND CERAMIC COMPONENTS COMPRISING THE SAME | KIRBY GLEN HAROLD | 2010-06-24 | — | — | US | disclosed |
| US-20100159151-A1 | METHODS FOR MAKING ENVIRONMENTAL BARRIER COATINGS AND CERAMIC COMPONENTS HAVING CMAS MITIGATION CAPABILITY | GENERAL ELECTRIC COMPANY | 2010-06-24 | — | — | US | disclosed |
| US-7399066-B2 | Piezoelectric element, ink jet recording head and producing method for piezoelectric element | CANON KABUSHIKI KAISHA (JP) | 2008-07-15 | — | — | US | disclosed |
| US-20050082943-A1 | Piezoelectric element, ink jet recording head and producing method for piezoelectric element | CANON KABUSHIKI KAISHA (JP) | 2005-04-21 | — | — | US | disclosed |
| US-20030143252-A1 | Inorganic/organic complexes for reducing skin irritation | PHILIPPE MICHEL (FR) | 2003-07-31 | — | — | US | disclosed |
| US-6521222-B1 | Topical cosmetics such as strontium 2,4-pentanedionate applied to keratin fibers, nails and/or mucous membranes for injuries, eczema, ulcers, fibrosis, psoriasis, pruritus, dermatitis, warts and for aging or wrinkle resistance | SOCIETE L'OREAL S.A. (FR) | 2003-02-18 | — | — | US | disclosed |
| EP-1092426-A1 | Use of inorganic-organic complexes whitin a composition | L'OREAL (FR) | 2001-04-18 | — | — | EP | disclosed |
| US-6211096-B1 | Tunable dielectric constant oxide and method of manufacture | LSI LOGIC CORPORATION | 2001-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030143252-A1 | Inorganic/organic complexes for reducing skin irritation | DEK, CUTA, TRPV2 | EGLN1 3759/4885KDM4E 2381/4885KDM6B 3530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.